News • Using AI nanopores
New rapid testing method for Covid-19
Researchers from Osaka University present a novel technique to detect different coronavirus variants quickly, including fast-spreading strains present in human saliva.
Testing devices
News • Preparing for the next pandemic
New rapid electronic diagnostic test for infectious diseases
A new molecular test for bacteria and viruses, including Sars-CoV-2, has been developed at the University of Surrey, as they warn that the world needs to be prepared for the next pandemic.
News • Spirometry distribution
The ‘silent scandal’ of missing lung tests across England
A new survey by The BMJ reveals shortages of vital diagnostic tests for respiratory conditions, such as COPD and asthma, across some of the most deprived areas of England.
Article • Cancer patients at risk
Blood test detects risk of neurotoxicity from CAR T-cell therapy
Chimeric antigen receptor (CAR) T-cell therapy is an immunotherapy treatment that re-engineers a patient’s own T-cells to help them attack malignant tumour cells. It has been very effective in the treatment of blood cancers, including certain types of leukaemia and lymphoma. However, two serious side effects are common as a result of the treatment: cytokine release syndrome (CRS) and immune…
News • MCED for 50+ cancer types
Multi-cancer blood test shows real promise
A trial of a new blood test for more than 50 types of cancer correctly revealed two out of every three cancers in more than 5,000 people who had visited their GP with suspected symptoms.
News • Pre-eclampsia
Detecting high-risk pregnancy with heart attack test
About 5% of all women develop pre-eclampsia during pregnancy, which in severe cases can become life-threatening for mother and child. Using commercially available troponin tests, high-risk patients could be identified much earlier and more accurately than before.
News • Molecular test for bacteria response
New method rapidly reveals antibiotic resistance
Researchers at Karolinska Institutet have developed a molecular method able to detect whether or not bacteria respond to antibiotics within minutes.
News • Perilous PSA policy
Prostate cancer ‘test by request’ drives overdiagnosis, argue experts
Experts argue that shared decision policies between patients and their doctors have led to high rates of PSA testing and clear medical harm, with minimal benefit and inequity.
News • Accuracy gain
Bowel cancer: double testing for better detection
Scientists from the University of Edinburgh have found that the accuracy of detecting bowel cancer is increased to almost 100% by carrying out a common test twice rather than once.
Article • Confirming initial positive findings
First-tier rapid serology testing for Lyme disease
Lyme disease, the most common tick-transmitted bacterial infection in the world, is challenging to diagnose. Initial early-stage symptoms may include skin rash, fever, headache, fatigue, swollen lymph nodes, and/or body and joint aches. However, these symptoms are also associated with many other diseases and medical conditions.
Sponsored • Promising combination: AFP, AFP-L3, DCP and GALAD score
Enhanced early detection of liver cancer
Worldwide, about one million people are suffering from hepatocellular carcinoma (HCC). In Germany alone, there are 9,000 new patients each year, most of them men between 50 and 60 years. When liver cancer is detected early, the prognosis is excellent, says Professor Dr. Ali Canbay, Director of the Medical Clinic at the University Hospital/Knappschaftskrankenhaus Bochum. While, unfortunately,…
Article • Cervix, vulva and vagina
More certainty with methylation tests for early detection of cancer
A second-generation lab test for early detection of cervical cancer is the most recent addition to Oncgnostics’ portfolio. In particular, the company’s solution will help women in countries with limited cancer screening. Moreover, new research on the early detection of vulval and vaginal cancer might soon enable the development of tests for these cancers.
News • Rapid screening diagnostic
94% accuracy: new prostate cancer blood test beats PSA method
Researchers have developed a new blood test to detect prostate cancer which displays greater accuracy than the current prostate-specific antigen (PSA) method.
News • Neurodegeneration assessment
New blood test differentiates Alzheimer’s disease from other dementias
A new blood test that can track and follow the neurodegeneration in Alzheimer's disease - and exclude other dementias.
News • "COMPASS" method
Using nanoparticles for more sensitive rapid tests
A newly developed rapid test needs only a few seconds to reliably detect pathogens such as SARS-CoV-2. It is based on specially designed magnetic nanoparticles.
News • Machine learning approach for screening
AI model predicts results of Covid-19 tests
A new study demonstrates that AI models, using symptom and demographic features, can help predict Covid-19 infections, providing a way for rapid screening and cost-effective infection detection.
News • High-sensitivity blood test
New cancer testing method to make regular monitoring affordable
Scientists from Singapore discovered a novel low-cost method of testing for cancers. The test sequences heated clinical samples to isolate cancer-specific signatures found in a patient’s blood.
News • Deadly heart inflammation
Hope for first blood test to detect myocarditis
The first blood test to diagnose inflammation of the heart muscle (myocarditis) could be in use in as little as a year, following the discovery of a molecular signal in the blood.
News • Appeal for sustainability
POCT: Why the medical sector must tackle its single-use diagnostic waste
During the Covid-19 pandemic, the use of these single-use diagnostics, or point-of-care tests has exploded. This is having major environmental consequences, experts point out.
Article • Early detection approach
Multi-cancer blood tests could shake up screening
New tests can identify over 50 types of cancer and boost detection of traditionally elusive cancers from tumour DNA in blood, researchers showed at the ESMO congress in September. These multi-cancer early detection (MCED) tests in development can spot common cancer signals and predict where the signal comes from in the body, results from a prospective investigation suggest.
News • Pathogen Analyzer
Researchers develop cost-effective PCR test alternative
Speed or accuracy? As far as Covid-19 tests go, this was the choice you had to make. In the future, this dilemma could be a thing of the past.
Sponsored • POCT
Pluslife Biotech – Mini Dock POC Molecular System
The Pluslife Mini Dock System is a Next-Generation POC molecular diagnostic tool that can be used in different application scenarios, which aims to help the decentralization of MDx in diagnosing facilities.
Article • Detecting several different diseases
Multiplex diagnostics: next-generation techniques for new challenges
With the rise of syndrome-style infections, co-infections and the current antimicrobial resistance challenges, the need for multiplexed diagnostics is now more important than ever.
Sponsored • Diagnostics Alliance against SARS-CoV-2
The Global Alliance for Diagnostics Sets Next-Generation POC Molecular Testing Collaboration
The coronavirus pandemic is a huge challenge for global public health and welfare. Decentralized, affordable POC MDx platforms would allow more effective control of SARS-CoV-2 and other infections.
Article • Prediction for breast, ovarian, cervical, and endometrial carcinoma
New test detects four women’s cancers from cervical screening samples
What if a test analysing cervical cells from a gynaecological swab could be used to detect four different female cancers at an early stage and also predict cancer risk over a healthy woman's lifetime? Researchers at the EUTOPS Institute in Innsbruck, Austria, are developing tests to do just that for breast, ovarian, cervical, and endometrial cancer detection.
